Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYTOKINETICS INC Director's Dealing 2024

Jun 11, 2024

30870_dirs_2024-06-11_a644f320-225c-4802-9728-caa7f8315cf0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2024-06-11

Reporting Person: Malik Fady Ibraham (EVP Research & Development)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-06-11 Common Stock M 5422 $7.96 Acquired 142792 Direct
2024-06-11 Common Stock S 5422 $53.05 Disposed 137370 Direct
2024-06-11 Common Stock S 2366 $53.03 Disposed 135004 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-06-11 Non-Qualified Stock Option (Right to Buy) $7.96 M 5422 Disposed 2025-02-26 Common Stock (5422) Direct